Cognizant has announced it has been selected by Novartis for a five-year, AI-enabled integrated IT operations engagement, expanding a strategic relationship that spans more than 20 years.
Théa and Unither Pharmaceuticals announce the signing of a long-term strategic industrial partnership aimed at supporting Théa Group’s growth in Europe.
EpilepsyGTx and ClearPoint Neuro have announced a partnership to support the targeted delivery of EpilepsyGTx’s lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).
Brenntag has announced a new strategic partnership with Evonik REXIM for the distribution of its GMP grade amino acids to the pharmaceutical and biopharmaceutical markets in Europe, effective 1st July 2026.
Hansa Biopharma and SERB S.A. has announced required regulatory approvals have been obtained and that the previously announced exclusive licensing transaction with SERB has closed.
Circio Holding and Tcelltech has announced a research collaboration to combine Circio's circVec circular RNA expression technology with Tcelltech's non-integrating nanoSMAR vector platform for the development of next gen engineered T-cell therapies.
Sartorius and LFB BIOMANUFACTURING have announced an expansion of their collaboration with the aim of offering biopharmaceutical clients a comprehensive CLD to first batch of GMP drug substance service.
Leica Biosystems, a Danaher company, has announced an expansion of its strategic collaboration with AstraZeneca and Daiichi Sankyo to develop an immunohistochemistry (IHC) assay and image analysis algorithm.
Er-Kim has announced that it has signed an exclusive agreement with LEO Pharma A/S to commercialise LOQTORZI (toripalimab) in select regions in Central and Eastern Europe (CEE).
Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical, a provider of advanced drug delivery systems, alongside an expansion of sterile fill-finish and autoinjector final assembly capacity at its Ridgefield, NJ site.
